Cargando…
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries
BACKGROUND: Managed entry agreements (MEAs) continue to emerge in health technology assessment (HTA)-based decision-making, to address evidentiary uncertainties arising therein. Evidence on the HTA criteria that influence MEAs' uptake remains scarce. This study explores the HTA criteria that de...
Autor principal: | Efthymiadou, Olina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406668/ https://www.ncbi.nlm.nih.gov/pubmed/36219363 http://dx.doi.org/10.1007/s10198-022-01526-x |
Ejemplares similares
-
Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
por: Efthymiadou, Olina, et al.
Publicado: (2022) -
Managed entry agreements
por: Muscolo, Luisa AA, et al.
Publicado: (2014) -
Efficacy, Safety, and Economics of Innovative Medicines: The Role of Multi-Criteria Decision Analysis and Managed Entry Agreements in Practice and Policy
por: Fens, Tanja, et al.
Publicado: (2021) -
The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment
por: Grimm, Sabine Elisabeth, et al.
Publicado: (2017) -
Does external reference pricing deliver what it promises? Evidence on its impact at national level
por: Kanavos, Panos, et al.
Publicado: (2019)